Usempax Ap en es it fr

Usempax Ap Brand names, Usempax Ap Analogs

Usempax Ap Brand Names Mixture

  • No information avaliable

Usempax Ap Chemical_Formula


Usempax Ap RX_link

Usempax Ap fda sheet

Usempax Ap msds (material safety sheet)

Usempax_Ap MSDS

Usempax Ap Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Usempax Ap Molecular Weight

284.74 g/mol

Usempax Ap Melting Point


Usempax Ap H2O Solubility

Slightly soluble (50 mg/L)

Usempax Ap State


Usempax Ap LogP


Usempax Ap Dosage Forms

Tablets; Injectable solution

Usempax Ap Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Usempax Ap Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Usempax Ap Absorption

Essentially complete, with a bioavailability of 93%.

Usempax Ap side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Usempax Ap Patient Information

Usempax Ap Organisms Affected

Humans and other mammals